Gene Symbol | Gene ID | Gene Info |
---|---|---|
MIXL1
|
ENSG00000185155.7 | Mix paired-like homeobox |
GSX1
|
ENSG00000169840.4 | GS homeobox 1 |
BSX
|
ENSG00000188909.4 | brain specific homeobox |
MEOX2
|
ENSG00000106511.5 | mesenchyme homeobox 2 |
LHX4
|
ENSG00000121454.4 | LIM homeobox 4 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr11_122854763_122855057 | BSX | 2482 | 0.283447 | -0.20 | 6.1e-01 | Click! |
chr11_122855667_122855916 | BSX | 3363 | 0.241757 | 0.17 | 6.7e-01 | Click! |
chr11_122855378_122855598 | BSX | 3060 | 0.252640 | 0.13 | 7.3e-01 | Click! |
chr11_122847569_122847720 | BSX | 4784 | 0.216183 | 0.13 | 7.4e-01 | Click! |
chr11_122855093_122855344 | BSX | 2790 | 0.265009 | -0.06 | 8.8e-01 | Click! |
chr13_28365753_28365974 | GSX1 | 917 | 0.630566 | -0.91 | 7.5e-04 | Click! |
chr13_28363625_28363776 | GSX1 | 3080 | 0.290233 | -0.81 | 8.7e-03 | Click! |
chr13_28365022_28365726 | GSX1 | 1406 | 0.472500 | -0.77 | 1.6e-02 | Click! |
chr13_28364199_28364350 | GSX1 | 2506 | 0.321935 | -0.75 | 1.9e-02 | Click! |
chr13_28371323_28371474 | GSX1 | 4618 | 0.243950 | 0.73 | 2.5e-02 | Click! |
chr1_180202492_180202643 | LHX4 | 3146 | 0.279549 | 0.57 | 1.1e-01 | Click! |
chr1_180182634_180182785 | LHX4 | 16712 | 0.193139 | 0.56 | 1.1e-01 | Click! |
chr1_180203614_180203822 | LHX4 | 4297 | 0.248788 | 0.51 | 1.6e-01 | Click! |
chr1_180216351_180216502 | LHX4 | 17005 | 0.195869 | 0.50 | 1.7e-01 | Click! |
chr1_180204707_180204858 | LHX4 | 5361 | 0.234876 | -0.44 | 2.4e-01 | Click! |
chr7_15791060_15791218 | MEOX2 | 64702 | 0.136387 | 0.78 | 1.2e-02 | Click! |
chr7_15960889_15961040 | MEOX2 | 234527 | 0.019950 | 0.74 | 2.4e-02 | Click! |
chr7_15790480_15790631 | MEOX2 | 64118 | 0.137575 | 0.72 | 3.0e-02 | Click! |
chr7_15726278_15726429 | MEOX2 | 84 | 0.980292 | 0.60 | 8.9e-02 | Click! |
chr7_15725909_15726109 | MEOX2 | 428 | 0.881158 | 0.59 | 9.7e-02 | Click! |
chr1_226411658_226412041 | MIXL1 | 530 | 0.782097 | -0.51 | 1.6e-01 | Click! |
chr1_226412063_226412214 | MIXL1 | 819 | 0.629574 | 0.20 | 6.0e-01 | Click! |
chr1_226411070_226411416 | MIXL1 | 76 | 0.973162 | -0.10 | 8.0e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr12_78336292_78336638 | 1.96 |
NAV3 |
neuron navigator 3 |
23591 |
0.28 |
chr7_129933276_129933885 | 1.73 |
CPA4 |
carboxypeptidase A4 |
461 |
0.76 |
chr18_53089837_53090372 | 1.44 |
TCF4 |
transcription factor 4 |
361 |
0.89 |
chr4_77506894_77507309 | 1.41 |
ENSG00000265314 |
. |
10397 |
0.17 |
chr8_37350646_37351319 | 1.24 |
RP11-150O12.6 |
|
23557 |
0.24 |
chr3_87036535_87037613 | 1.21 |
VGLL3 |
vestigial like 3 (Drosophila) |
2778 |
0.42 |
chr21_17909068_17909746 | 1.20 |
ENSG00000207638 |
. |
2002 |
0.33 |
chr20_46412966_46413363 | 1.19 |
SULF2 |
sulfatase 2 |
1069 |
0.59 |
chr11_131780111_131780399 | 1.14 |
NTM |
neurotrimin |
642 |
0.77 |
chr1_45083000_45083241 | 1.11 |
RNF220 |
ring finger protein 220 |
8878 |
0.17 |
chr5_1883178_1883404 | 1.10 |
IRX4 |
iroquois homeobox 4 |
411 |
0.66 |
chr1_68697735_68698156 | 1.09 |
WLS |
wntless Wnt ligand secretion mediator |
18 |
0.98 |
chr21_36254420_36254945 | 1.09 |
RUNX1 |
runt-related transcription factor 1 |
4798 |
0.34 |
chr9_18474095_18474958 | 1.08 |
ADAMTSL1 |
ADAMTS-like 1 |
295 |
0.95 |
chr1_87799796_87800719 | 1.05 |
LMO4 |
LIM domain only 4 |
2906 |
0.4 |
chr13_38172411_38172686 | 1.05 |
POSTN |
periostin, osteoblast specific factor |
315 |
0.95 |
chr3_33318777_33319866 | 1.05 |
FBXL2 |
F-box and leucine-rich repeat protein 2 |
353 |
0.91 |
chr5_147836900_147837051 | 1.05 |
CTD-2283N19.1 |
|
26605 |
0.18 |
chr1_179111271_179111703 | 1.05 |
ABL2 |
c-abl oncogene 2, non-receptor tyrosine kinase |
692 |
0.72 |
chr20_50384318_50384901 | 1.04 |
ATP9A |
ATPase, class II, type 9A |
258 |
0.94 |
chr10_33622034_33622426 | 1.04 |
NRP1 |
neuropilin 1 |
1080 |
0.63 |
chr10_114714851_114715858 | 1.02 |
RP11-57H14.2 |
|
3720 |
0.26 |
chr4_141015619_141015856 | 1.01 |
RP11-392B6.1 |
|
33432 |
0.2 |
chr8_42063953_42065062 | 1.01 |
PLAT |
plasminogen activator, tissue |
576 |
0.71 |
chr2_207998546_207999225 | 1.00 |
KLF7 |
Kruppel-like factor 7 (ubiquitous) |
24 |
0.98 |
chr12_56917781_56918152 | 1.00 |
RBMS2 |
RNA binding motif, single stranded interacting protein 2 |
2183 |
0.23 |
chr7_95107815_95108198 | 1.00 |
ASB4 |
ankyrin repeat and SOCS box containing 4 |
7207 |
0.2 |
chr4_124339424_124339730 | 0.99 |
SPRY1 |
sprouty homolog 1, antagonist of FGF signaling (Drosophila) |
18454 |
0.3 |
chr18_53090404_53090609 | 0.99 |
TCF4 |
transcription factor 4 |
763 |
0.7 |
chr3_150089259_150089633 | 0.96 |
TSC22D2 |
TSC22 domain family, member 2 |
36676 |
0.21 |
chr22_46462951_46463814 | 0.96 |
RP6-109B7.4 |
|
2389 |
0.16 |
chr17_33391542_33391948 | 0.94 |
RFFL |
ring finger and FYVE-like domain containing E3 ubiquitin protein ligase |
874 |
0.45 |
chr4_153272766_153273041 | 0.94 |
FBXW7 |
F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase |
1220 |
0.52 |
chr17_79317268_79317735 | 0.94 |
TMEM105 |
transmembrane protein 105 |
13027 |
0.13 |
chr8_131206424_131206650 | 0.93 |
ASAP1 |
ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 |
13429 |
0.23 |
chr6_116833589_116833880 | 0.93 |
TRAPPC3L |
trafficking protein particle complex 3-like |
228 |
0.83 |
chr11_106239153_106239583 | 0.93 |
RP11-680E19.1 |
|
104326 |
0.08 |
chr1_77464464_77464931 | 0.92 |
ENSG00000221720 |
. |
8732 |
0.27 |
chr21_17442999_17443232 | 0.92 |
ENSG00000252273 |
. |
35286 |
0.24 |
chr1_159111648_159111897 | 0.92 |
AIM2 |
absent in melanoma 2 |
1474 |
0.37 |
chr3_150131821_150132388 | 0.90 |
TSC22D2 |
TSC22 domain family, member 2 |
3308 |
0.35 |
chr7_17720120_17720505 | 0.88 |
SNX13 |
sorting nexin 13 |
259779 |
0.02 |
chr20_45754385_45754678 | 0.88 |
ENSG00000264901 |
. |
41078 |
0.18 |
chr12_46949518_46949939 | 0.88 |
SLC38A2 |
solute carrier family 38, member 2 |
183078 |
0.03 |
chr4_61665381_61665532 | 0.88 |
ENSG00000265829 |
. |
122881 |
0.06 |
chr5_3597777_3597928 | 0.88 |
IRX1 |
iroquois homeobox 1 |
1684 |
0.41 |
chr12_78334342_78334902 | 0.88 |
NAV3 |
neuron navigator 3 |
25434 |
0.27 |
chr6_157381110_157381404 | 0.87 |
RP1-137K2.2 |
|
59583 |
0.15 |
chr9_100069620_100070257 | 0.87 |
CCDC180 |
coiled-coil domain containing 180 |
3 |
0.98 |
chr2_55272861_55273322 | 0.86 |
RTN4 |
reticulon 4 |
931 |
0.61 |
chr3_126500993_126501380 | 0.86 |
CHCHD6 |
coiled-coil-helix-coiled-coil-helix domain containing 6 |
51779 |
0.16 |
chr2_161522670_161522919 | 0.86 |
RBMS1 |
RNA binding motif, single stranded interacting protein 1 |
172489 |
0.03 |
chr4_41215270_41215769 | 0.86 |
APBB2 |
amyloid beta (A4) precursor protein-binding, family B, member 2 |
956 |
0.59 |
chr6_147528870_147529159 | 0.86 |
STXBP5 |
syntaxin binding protein 5 (tomosyn) |
1904 |
0.39 |
chr1_225839301_225840394 | 0.85 |
ENAH |
enabled homolog (Drosophila) |
571 |
0.78 |
chr9_104248314_104249564 | 0.85 |
TMEM246 |
transmembrane protein 246 |
460 |
0.79 |
chr3_98700853_98701271 | 0.84 |
ENSG00000207331 |
. |
73759 |
0.1 |
chr3_79216626_79216907 | 0.84 |
ROBO1 |
roundabout, axon guidance receptor, homolog 1 (Drosophila) |
148157 |
0.05 |
chr7_98970111_98970529 | 0.83 |
ARPC1B |
actin related protein 2/3 complex, subunit 1B, 41kDa |
1552 |
0.28 |
chr12_76271592_76272084 | 0.83 |
ENSG00000243420 |
. |
80072 |
0.1 |
chr15_101728252_101728749 | 0.83 |
CHSY1 |
chondroitin sulfate synthase 1 |
63637 |
0.1 |
chr6_19691587_19692480 | 0.81 |
ENSG00000200957 |
. |
49273 |
0.18 |
chr1_214723042_214723197 | 0.81 |
PTPN14 |
protein tyrosine phosphatase, non-receptor type 14 |
1447 |
0.54 |
chr1_182992978_182993852 | 0.81 |
LAMC1 |
laminin, gamma 1 (formerly LAMB2) |
820 |
0.64 |
chr10_24754741_24755189 | 0.80 |
KIAA1217 |
KIAA1217 |
495 |
0.84 |
chr1_233723927_233724223 | 0.80 |
KCNK1 |
potassium channel, subfamily K, member 1 |
25675 |
0.21 |
chr12_115135696_115136278 | 0.80 |
TBX3 |
T-box 3 |
14018 |
0.21 |
chr16_54961062_54961213 | 0.79 |
IRX5 |
iroquois homeobox 5 |
3637 |
0.38 |
chr3_134050593_134051228 | 0.78 |
AMOTL2 |
angiomotin like 2 |
39844 |
0.16 |
chr8_121137253_121137925 | 0.78 |
COL14A1 |
collagen, type XIV, alpha 1 |
237 |
0.96 |
chr5_92943123_92943644 | 0.77 |
ENSG00000251725 |
. |
13111 |
0.2 |
chr12_50665639_50665877 | 0.77 |
LIMA1 |
LIM domain and actin binding 1 |
11509 |
0.13 |
chr8_127837007_127837644 | 0.77 |
ENSG00000212451 |
. |
153558 |
0.04 |
chr9_79483882_79484033 | 0.77 |
PRUNE2 |
prune homolog 2 (Drosophila) |
37044 |
0.21 |
chr15_88020923_88021173 | 0.77 |
ENSG00000207150 |
. |
3528 |
0.4 |
chr18_21850703_21850950 | 0.77 |
OSBPL1A |
oxysterol binding protein-like 1A |
1370 |
0.35 |
chr4_157997366_157997978 | 0.77 |
GLRB |
glycine receptor, beta |
117 |
0.97 |
chr5_128796390_128797012 | 0.76 |
ADAMTS19-AS1 |
ADAMTS19 antisense RNA 1 |
319 |
0.77 |
chr5_82767889_82768074 | 0.76 |
VCAN |
versican |
237 |
0.96 |
chr11_24518160_24518510 | 0.76 |
LUZP2 |
leucine zipper protein 2 |
389 |
0.91 |
chr17_65427494_65427948 | 0.76 |
ENSG00000201547 |
. |
22724 |
0.12 |
chr20_14315841_14316127 | 0.76 |
FLRT3 |
fibronectin leucine rich transmembrane protein 3 |
2270 |
0.36 |
chr9_22008020_22008450 | 0.75 |
CDKN2B |
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) |
717 |
0.61 |
chr9_110818837_110819103 | 0.75 |
ENSG00000222459 |
. |
137711 |
0.05 |
chr15_71054590_71054766 | 0.75 |
UACA |
uveal autoantigen with coiled-coil domains and ankyrin repeats |
1091 |
0.55 |
chr7_84267660_84267811 | 0.75 |
ENSG00000265050 |
. |
27589 |
0.27 |
chrX_46652199_46652509 | 0.75 |
SLC9A7 |
solute carrier family 9, subfamily A (NHE7, cation proton antiporter 7), member 7 |
33864 |
0.17 |
chr5_86416729_86416961 | 0.75 |
ENSG00000265919 |
. |
6074 |
0.24 |
chr21_40357766_40357986 | 0.75 |
ENSG00000272015 |
. |
91167 |
0.09 |
chr9_96819103_96819334 | 0.74 |
PTPDC1 |
protein tyrosine phosphatase domain containing 1 |
26142 |
0.21 |
chr10_13569370_13569685 | 0.74 |
RP11-214D15.2 |
|
989 |
0.36 |
chr10_12746098_12746480 | 0.74 |
ENSG00000221331 |
. |
21063 |
0.25 |
chr13_40174017_40174396 | 0.73 |
LHFP |
lipoma HMGIC fusion partner |
3102 |
0.29 |
chr11_123178720_123179203 | 0.73 |
ENSG00000200496 |
. |
6863 |
0.25 |
chr6_85823864_85824548 | 0.73 |
NT5E |
5'-nucleotidase, ecto (CD73) |
335603 |
0.01 |
chr1_198238845_198238996 | 0.73 |
NEK7 |
NIMA-related kinase 7 |
48991 |
0.19 |
chr4_14728626_14728777 | 0.73 |
ENSG00000202449 |
. |
36367 |
0.24 |
chr6_167033822_167034287 | 0.73 |
RPS6KA2 |
ribosomal protein S6 kinase, 90kDa, polypeptide 2 |
6671 |
0.27 |
chr4_157692811_157693135 | 0.72 |
RP11-154F14.2 |
|
69538 |
0.11 |
chr1_196577911_196578299 | 0.72 |
KCNT2 |
potassium channel, subfamily T, member 2 |
250 |
0.94 |
chr20_14316163_14316462 | 0.72 |
FLRT3 |
fibronectin leucine rich transmembrane protein 3 |
1942 |
0.4 |
chr5_16916952_16917142 | 0.72 |
MYO10 |
myosin X |
411 |
0.87 |
chr7_157140270_157140421 | 0.72 |
DNAJB6 |
DnaJ (Hsp40) homolog, subfamily B, member 6 |
7830 |
0.25 |
chr9_40632604_40633916 | 0.71 |
SPATA31A3 |
SPATA31 subfamily A, member 3 |
67031 |
0.14 |
chr1_31480017_31480289 | 0.71 |
PUM1 |
pumilio RNA-binding family member 1 |
12202 |
0.19 |
chr15_96878465_96878729 | 0.71 |
ENSG00000222651 |
. |
2107 |
0.24 |
chr6_139116835_139117557 | 0.71 |
ECT2L |
epithelial cell transforming sequence 2 oncogene-like |
61 |
0.98 |
chr3_93895824_93896204 | 0.71 |
ENSG00000253062 |
. |
78604 |
0.1 |
chr15_96884556_96884898 | 0.71 |
ENSG00000222651 |
. |
8237 |
0.16 |
chr11_27740250_27740471 | 0.70 |
BDNF |
brain-derived neurotrophic factor |
934 |
0.68 |
chr15_99788624_99789059 | 0.70 |
TTC23 |
tetratricopeptide repeat domain 23 |
895 |
0.51 |
chr7_134465735_134465936 | 0.70 |
CALD1 |
caldesmon 1 |
1406 |
0.57 |
chr1_9953446_9953936 | 0.70 |
CTNNBIP1 |
catenin, beta interacting protein 1 |
396 |
0.8 |
chr10_4285552_4285907 | 0.70 |
ENSG00000207124 |
. |
271415 |
0.02 |
chr7_98029134_98029377 | 0.70 |
BAIAP2L1 |
BAI1-associated protein 2-like 1 |
1125 |
0.59 |
chr21_30517898_30518405 | 0.69 |
ENSG00000201984 |
. |
6446 |
0.14 |
chr3_157822422_157822707 | 0.69 |
SHOX2 |
short stature homeobox 2 |
519 |
0.7 |
chr7_24988449_24988600 | 0.69 |
OSBPL3 |
oxysterol binding protein-like 3 |
30812 |
0.21 |
chr15_96881380_96881711 | 0.68 |
ENSG00000222651 |
. |
5055 |
0.17 |
chr3_190530283_190530682 | 0.68 |
GMNC |
geminin coiled-coil domain containing |
49922 |
0.18 |
chr8_89311514_89311910 | 0.68 |
RP11-586K2.1 |
|
27353 |
0.2 |
chrX_114829080_114829277 | 0.68 |
PLS3 |
plastin 3 |
1313 |
0.48 |
chr10_69831641_69832005 | 0.67 |
HERC4 |
HECT and RLD domain containing E3 ubiquitin protein ligase 4 |
2071 |
0.33 |
chr12_66286178_66286489 | 0.67 |
RP11-366L20.2 |
Uncharacterized protein |
10386 |
0.18 |
chr2_227590884_227591406 | 0.67 |
ENSG00000263363 |
. |
67636 |
0.11 |
chr11_122029721_122030081 | 0.67 |
ENSG00000207994 |
. |
6885 |
0.18 |
chr5_174178214_174178699 | 0.67 |
ENSG00000266890 |
. |
281 |
0.94 |
chr8_87188438_87188625 | 0.67 |
CTD-3118D11.3 |
|
4116 |
0.24 |
chr21_36256046_36256553 | 0.67 |
RUNX1 |
runt-related transcription factor 1 |
3181 |
0.38 |
chr12_80081544_80081908 | 0.67 |
PAWR |
PRKC, apoptosis, WT1, regulator |
2134 |
0.41 |
chr1_102791433_102791584 | 0.67 |
OLFM3 |
olfactomedin 3 |
328922 |
0.01 |
chr4_134070427_134071051 | 0.66 |
PCDH10 |
protocadherin 10 |
269 |
0.96 |
chr17_45698884_45699286 | 0.66 |
NPEPPS |
aminopeptidase puromycin sensitive |
3369 |
0.19 |
chr9_4137636_4137913 | 0.66 |
GLIS3 |
GLIS family zinc finger 3 |
7419 |
0.28 |
chr2_3626466_3626991 | 0.66 |
ENSG00000252531 |
. |
1432 |
0.27 |
chr15_96878987_96879612 | 0.66 |
ENSG00000222651 |
. |
2809 |
0.21 |
chr5_73839186_73839374 | 0.66 |
HEXB |
hexosaminidase B (beta polypeptide) |
96568 |
0.07 |
chr8_93114852_93115389 | 0.66 |
RUNX1T1 |
runt-related transcription factor 1; translocated to, 1 (cyclin D-related) |
334 |
0.94 |
chr11_121966638_121966789 | 0.66 |
ENSG00000207971 |
. |
3839 |
0.19 |
chr3_71907377_71907649 | 0.66 |
ENSG00000239250 |
. |
31185 |
0.2 |
chrX_86773476_86773748 | 0.65 |
KLHL4 |
kelch-like family member 4 |
795 |
0.74 |
chr5_131991447_131991948 | 0.65 |
AC004041.2 |
|
113 |
0.94 |
chr5_53753293_53753597 | 0.65 |
HSPB3 |
heat shock 27kDa protein 3 |
2000 |
0.44 |
chr15_37179413_37179956 | 0.65 |
ENSG00000212511 |
. |
34843 |
0.22 |
chr16_4424352_4424847 | 0.65 |
VASN |
vasorin |
2750 |
0.17 |
chr4_170188382_170188561 | 0.65 |
SH3RF1 |
SH3 domain containing ring finger 1 |
2637 |
0.38 |
chr2_164591489_164591640 | 0.65 |
FIGN |
fidgetin |
953 |
0.74 |
chr9_43685829_43685980 | 0.64 |
CNTNAP3B |
contactin associated protein-like 3B |
994 |
0.67 |
chr7_107638965_107639116 | 0.64 |
ENSG00000238297 |
. |
1387 |
0.38 |
chr20_59830411_59830643 | 0.64 |
CDH4 |
cadherin 4, type 1, R-cadherin (retinal) |
3045 |
0.42 |
chr1_225842736_225843127 | 0.64 |
ENAH |
enabled homolog (Drosophila) |
2087 |
0.34 |
chr3_159483781_159484285 | 0.64 |
IQCJ-SCHIP1 |
IQCJ-SCHIP1 readthrough |
1141 |
0.44 |
chr9_94065254_94065575 | 0.64 |
AUH |
AU RNA binding protein/enoyl-CoA hydratase |
58763 |
0.16 |
chr6_148829582_148830289 | 0.64 |
ENSG00000223322 |
. |
15441 |
0.29 |
chr1_84107245_84107582 | 0.64 |
ENSG00000223231 |
. |
152147 |
0.04 |
chr3_89074301_89074693 | 0.63 |
EPHA3 |
EPH receptor A3 |
82177 |
0.12 |
chr6_148663224_148663375 | 0.63 |
SASH1 |
SAM and SH3 domain containing 1 |
430 |
0.89 |
chr15_48436377_48436744 | 0.63 |
MYEF2 |
myelin expression factor 2 |
4963 |
0.17 |
chr8_57086542_57086822 | 0.63 |
PLAG1 |
pleiomorphic adenoma gene 1 |
37156 |
0.12 |
chr13_33787837_33788166 | 0.63 |
STARD13 |
StAR-related lipid transfer (START) domain containing 13 |
7858 |
0.24 |
chr18_33057581_33058355 | 0.63 |
INO80C |
INO80 complex subunit C |
9466 |
0.21 |
chr3_128207705_128209147 | 0.63 |
RP11-475N22.4 |
|
326 |
0.79 |
chr17_70113469_70114161 | 0.62 |
SOX9 |
SRY (sex determining region Y)-box 9 |
3346 |
0.37 |
chr3_191049544_191049695 | 0.62 |
UTS2B |
urotensin 2B |
1294 |
0.47 |
chr9_65576390_65577630 | 0.62 |
SPATA31A7 |
SPATA31 subfamily A, member 7 |
67400 |
0.15 |
chr1_28390431_28390759 | 0.62 |
EYA3 |
eyes absent homolog 3 (Drosophila) |
5997 |
0.17 |
chr4_157891142_157892336 | 0.62 |
PDGFC |
platelet derived growth factor C |
316 |
0.91 |
chr5_122182822_122182973 | 0.62 |
SNX24 |
sorting nexin 24 |
1576 |
0.38 |
chr9_89952337_89952906 | 0.62 |
ENSG00000212421 |
. |
77256 |
0.11 |
chr16_54968513_54968925 | 0.62 |
IRX5 |
iroquois homeobox 5 |
2735 |
0.43 |
chr16_54969464_54969709 | 0.62 |
IRX5 |
iroquois homeobox 5 |
3602 |
0.39 |
chr16_25345657_25345808 | 0.62 |
ZKSCAN2 |
zinc finger with KRAB and SCAN domains 2 |
76480 |
0.1 |
chr10_33798417_33798757 | 0.62 |
NRP1 |
neuropilin 1 |
173397 |
0.03 |
chr7_116312981_116313724 | 0.62 |
MET |
met proto-oncogene |
893 |
0.68 |
chr5_149867786_149868254 | 0.61 |
NDST1 |
N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 1 |
2163 |
0.3 |
chr3_79066759_79066910 | 0.61 |
ROBO1 |
roundabout, axon guidance receptor, homolog 1 (Drosophila) |
860 |
0.75 |
chr2_24123591_24123937 | 0.61 |
ATAD2B |
ATPase family, AAA domain containing 2B |
26171 |
0.17 |
chr14_29859562_29859789 | 0.61 |
ENSG00000257522 |
. |
11813 |
0.29 |
chr4_81191052_81191243 | 0.61 |
FGF5 |
fibroblast growth factor 5 |
3354 |
0.31 |
chr9_112813674_112813882 | 0.61 |
AKAP2 |
A kinase (PRKA) anchor protein 2 |
2802 |
0.39 |
chr1_215179099_215179440 | 0.61 |
KCNK2 |
potassium channel, subfamily K, member 2 |
71 |
0.99 |
chr13_30002091_30002575 | 0.60 |
MTUS2 |
microtubule associated tumor suppressor candidate 2 |
431 |
0.89 |
chr3_172035927_172036370 | 0.60 |
AC092964.1 |
Uncharacterized protein |
1930 |
0.38 |
chr4_15685369_15685921 | 0.60 |
FAM200B |
family with sequence similarity 200, member B |
2216 |
0.26 |
chr8_32440879_32441165 | 0.60 |
NRG1 |
neuregulin 1 |
22144 |
0.27 |
chr8_12986347_12986498 | 0.60 |
DLC1 |
deleted in liver cancer 1 |
4561 |
0.27 |
chr18_20612011_20612377 | 0.60 |
ENSG00000223023 |
. |
7635 |
0.17 |
chr6_106577764_106578076 | 0.60 |
RP1-134E15.3 |
|
29905 |
0.19 |
chr12_66222342_66222753 | 0.60 |
HMGA2 |
high mobility group AT-hook 2 |
3644 |
0.26 |
chr3_14212156_14212441 | 0.60 |
LSM3 |
LSM3 homolog, U6 small nuclear RNA associated (S. cerevisiae) |
7560 |
0.16 |
chr2_17801837_17802176 | 0.60 |
VSNL1 |
visinin-like 1 |
79579 |
0.1 |
chr11_15135960_15136328 | 0.60 |
INSC |
inscuteable homolog (Drosophila) |
340 |
0.92 |
chr4_183370400_183371073 | 0.59 |
TENM3 |
teneurin transmembrane protein 3 |
584 |
0.84 |
chr10_74854370_74854615 | 0.59 |
P4HA1 |
prolyl 4-hydroxylase, alpha polypeptide I |
2116 |
0.19 |
chr4_114357002_114357251 | 0.59 |
ENSG00000206820 |
. |
15647 |
0.2 |
chr9_89021021_89021390 | 0.59 |
ENSG00000222293 |
. |
16838 |
0.24 |
chr4_95376265_95376416 | 0.59 |
PDLIM5 |
PDZ and LIM domain 5 |
56 |
0.99 |
chr22_36233928_36234199 | 0.59 |
RBFOX2 |
RNA binding protein, fox-1 homolog (C. elegans) 2 |
2202 |
0.43 |
chr9_21677527_21678485 | 0.59 |
ENSG00000244230 |
. |
21307 |
0.21 |
chr21_36253539_36254227 | 0.59 |
RUNX1 |
runt-related transcription factor 1 |
5597 |
0.33 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 2.7 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.7 | 2.0 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.7 | 2.0 | GO:0050923 | regulation of negative chemotaxis(GO:0050923) |
0.4 | 1.6 | GO:0060013 | righting reflex(GO:0060013) |
0.4 | 2.0 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.4 | 1.2 | GO:0072201 | negative regulation of mesenchymal cell proliferation(GO:0072201) |
0.3 | 1.0 | GO:0055098 | response to low-density lipoprotein particle(GO:0055098) |
0.3 | 1.0 | GO:1900115 | sequestering of extracellular ligand from receptor(GO:0035581) sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.3 | 0.9 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.3 | 0.9 | GO:0010766 | negative regulation of sodium ion transport(GO:0010766) |
0.3 | 1.8 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) regulation of dendritic spine morphogenesis(GO:0061001) dendritic spine organization(GO:0097061) |
0.3 | 0.9 | GO:0072047 | proximal/distal pattern formation involved in nephron development(GO:0072047) specification of nephron tubule identity(GO:0072081) |
0.3 | 0.8 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.3 | 1.1 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.3 | 0.3 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.3 | 0.3 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
0.3 | 0.8 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.3 | 1.8 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.2 | 0.5 | GO:0032413 | negative regulation of ion transmembrane transporter activity(GO:0032413) |
0.2 | 0.7 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.2 | 0.9 | GO:0070141 | response to UV-A(GO:0070141) |
0.2 | 0.4 | GO:0002072 | optic cup morphogenesis involved in camera-type eye development(GO:0002072) |
0.2 | 1.3 | GO:0022617 | extracellular matrix disassembly(GO:0022617) |
0.2 | 0.8 | GO:0009158 | purine nucleoside monophosphate catabolic process(GO:0009128) ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.2 | 0.8 | GO:0048875 | surfactant homeostasis(GO:0043129) chemical homeostasis within a tissue(GO:0048875) |
0.2 | 0.6 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.2 | 0.2 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.2 | 0.4 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.2 | 0.8 | GO:0008218 | bioluminescence(GO:0008218) |
0.2 | 1.3 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.2 | 0.7 | GO:0010659 | striated muscle cell apoptotic process(GO:0010658) cardiac muscle cell apoptotic process(GO:0010659) regulation of striated muscle cell apoptotic process(GO:0010662) negative regulation of striated muscle cell apoptotic process(GO:0010664) regulation of cardiac muscle cell apoptotic process(GO:0010665) negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
0.2 | 0.4 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.2 | 0.5 | GO:0032509 | endosome transport via multivesicular body sorting pathway(GO:0032509) |
0.2 | 0.2 | GO:0003402 | planar cell polarity pathway involved in axis elongation(GO:0003402) |
0.2 | 0.5 | GO:0060346 | bone trabecula formation(GO:0060346) bone trabecula morphogenesis(GO:0061430) |
0.2 | 0.3 | GO:0060129 | thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
0.2 | 1.0 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.2 | 0.8 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) positive regulation of sprouting angiogenesis(GO:1903672) |
0.2 | 0.6 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
0.2 | 0.2 | GO:0072048 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) |
0.2 | 0.5 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.1 | 0.3 | GO:0072010 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.1 | 0.3 | GO:0060242 | contact inhibition(GO:0060242) |
0.1 | 0.3 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.1 | 0.9 | GO:1904893 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.1 | 0.1 | GO:0060433 | bronchus development(GO:0060433) |
0.1 | 0.3 | GO:0060435 | bronchiole development(GO:0060435) |
0.1 | 1.3 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.1 | 0.6 | GO:0021898 | commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
0.1 | 0.1 | GO:0071481 | cellular response to X-ray(GO:0071481) |
0.1 | 0.6 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.1 | 0.6 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.1 | 1.5 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.1 | 0.3 | GO:0007500 | mesodermal cell fate determination(GO:0007500) |
0.1 | 0.4 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.1 | 0.6 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.1 | 0.4 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
0.1 | 0.5 | GO:0010107 | potassium ion import(GO:0010107) |
0.1 | 1.5 | GO:0035329 | hippo signaling(GO:0035329) |
0.1 | 0.2 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.1 | 0.2 | GO:0051940 | regulation of neurotransmitter uptake(GO:0051580) regulation of dopamine uptake involved in synaptic transmission(GO:0051584) regulation of catecholamine uptake involved in synaptic transmission(GO:0051940) |
0.1 | 0.2 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.1 | 0.5 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.1 | 0.1 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.1 | 0.5 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
0.1 | 0.8 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.1 | 0.5 | GO:0033197 | response to vitamin E(GO:0033197) |
0.1 | 0.2 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.1 | 0.4 | GO:0060638 | mesenchymal-epithelial cell signaling(GO:0060638) |
0.1 | 0.1 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.1 | 0.2 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.1 | 0.5 | GO:0001547 | antral ovarian follicle growth(GO:0001547) |
0.1 | 1.1 | GO:0030219 | megakaryocyte differentiation(GO:0030219) |
0.1 | 0.1 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
0.1 | 0.4 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.1 | 0.3 | GO:0010842 | retina layer formation(GO:0010842) |
0.1 | 0.1 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.1 | 0.4 | GO:0008354 | germ cell migration(GO:0008354) |
0.1 | 0.4 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.1 | 2.0 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.1 | 0.4 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
0.1 | 0.2 | GO:0060677 | ureteric bud elongation(GO:0060677) |
0.1 | 0.4 | GO:0048539 | bone marrow development(GO:0048539) |
0.1 | 0.5 | GO:0042983 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.1 | 0.3 | GO:0060174 | limb bud formation(GO:0060174) |
0.1 | 0.3 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.1 | 0.3 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
0.1 | 0.3 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.1 | 0.3 | GO:0003308 | negative regulation of Wnt signaling pathway involved in heart development(GO:0003308) |
0.1 | 1.7 | GO:0008038 | neuron recognition(GO:0008038) |
0.1 | 0.3 | GO:0042482 | positive regulation of odontogenesis(GO:0042482) |
0.1 | 0.3 | GO:0051142 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
0.1 | 0.3 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.1 | 2.1 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
0.1 | 0.1 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.1 | 0.3 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.1 | 0.3 | GO:0032909 | transforming growth factor beta2 production(GO:0032906) regulation of transforming growth factor beta2 production(GO:0032909) |
0.1 | 0.5 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.1 | 0.1 | GO:0046015 | carbon catabolite regulation of transcription(GO:0045990) regulation of transcription by glucose(GO:0046015) |
0.1 | 0.2 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.1 | 0.6 | GO:0008347 | glial cell migration(GO:0008347) |
0.1 | 0.1 | GO:0031223 | auditory behavior(GO:0031223) |
0.1 | 0.2 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.1 | 0.3 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.1 | 0.2 | GO:0045655 | regulation of monocyte differentiation(GO:0045655) |
0.1 | 0.2 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.1 | 0.2 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.1 | 0.2 | GO:0010159 | specification of organ position(GO:0010159) |
0.1 | 0.1 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
0.1 | 0.3 | GO:0010042 | response to manganese ion(GO:0010042) |
0.1 | 0.2 | GO:0032236 | obsolete positive regulation of calcium ion transport via store-operated calcium channel activity(GO:0032236) |
0.1 | 0.2 | GO:0061036 | positive regulation of cartilage development(GO:0061036) |
0.1 | 0.2 | GO:0045002 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) double-strand break repair via single-strand annealing(GO:0045002) |
0.1 | 0.2 | GO:0010193 | response to ozone(GO:0010193) |
0.1 | 0.2 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
0.1 | 1.5 | GO:0048010 | vascular endothelial growth factor receptor signaling pathway(GO:0048010) |
0.1 | 0.1 | GO:0002138 | retinoic acid biosynthetic process(GO:0002138) diterpenoid biosynthetic process(GO:0016102) |
0.1 | 0.1 | GO:0032347 | regulation of ketone biosynthetic process(GO:0010566) regulation of aldosterone metabolic process(GO:0032344) regulation of aldosterone biosynthetic process(GO:0032347) |
0.1 | 0.1 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.1 | 0.1 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.1 | 0.2 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
0.1 | 3.6 | GO:0034332 | adherens junction organization(GO:0034332) |
0.1 | 0.6 | GO:0002076 | osteoblast development(GO:0002076) |
0.1 | 0.4 | GO:0030853 | negative regulation of granulocyte differentiation(GO:0030853) |
0.1 | 1.1 | GO:0042730 | fibrinolysis(GO:0042730) |
0.1 | 0.5 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
0.1 | 0.3 | GO:0034063 | stress granule assembly(GO:0034063) |
0.1 | 0.5 | GO:0015871 | choline transport(GO:0015871) |
0.1 | 0.7 | GO:0032330 | regulation of chondrocyte differentiation(GO:0032330) |
0.1 | 0.1 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) oligodendrocyte cell fate specification(GO:0021778) glial cell fate specification(GO:0021780) |
0.1 | 0.1 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.1 | 0.2 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.1 | 0.2 | GO:0018243 | protein O-linked glycosylation via serine(GO:0018242) protein O-linked glycosylation via threonine(GO:0018243) |
0.1 | 0.3 | GO:0032410 | negative regulation of transporter activity(GO:0032410) |
0.1 | 0.1 | GO:0021521 | ventral spinal cord interneuron specification(GO:0021521) regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) cell fate specification involved in pattern specification(GO:0060573) |
0.1 | 0.3 | GO:0009415 | response to water deprivation(GO:0009414) response to water(GO:0009415) |
0.1 | 0.5 | GO:0001660 | fever generation(GO:0001660) |
0.1 | 0.2 | GO:1903332 | regulation of protein folding(GO:1903332) |
0.1 | 0.6 | GO:0099518 | vesicle transport along microtubule(GO:0047496) vesicle cytoskeletal trafficking(GO:0099518) |
0.1 | 0.2 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.1 | 0.1 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.1 | 0.2 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.1 | 0.2 | GO:0007172 | signal complex assembly(GO:0007172) |
0.1 | 0.2 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.1 | 1.0 | GO:0021766 | hippocampus development(GO:0021766) |
0.1 | 1.2 | GO:0051353 | positive regulation of oxidoreductase activity(GO:0051353) |
0.1 | 0.2 | GO:0001945 | lymph vessel development(GO:0001945) |
0.1 | 0.2 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.1 | 0.1 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.1 | 0.1 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.1 | 0.1 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
0.1 | 0.1 | GO:0090049 | regulation of cell migration involved in sprouting angiogenesis(GO:0090049) regulation of sprouting angiogenesis(GO:1903670) |
0.1 | 0.3 | GO:0016246 | RNA interference(GO:0016246) |
0.1 | 0.1 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.1 | 0.2 | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) |
0.1 | 0.1 | GO:0071379 | cellular response to prostaglandin stimulus(GO:0071379) |
0.1 | 0.7 | GO:0048538 | thymus development(GO:0048538) |
0.1 | 0.2 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
0.1 | 0.2 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.1 | 0.1 | GO:1903579 | negative regulation of nucleoside metabolic process(GO:0045978) negative regulation of ATP metabolic process(GO:1903579) |
0.1 | 0.1 | GO:0010454 | negative regulation of cell fate commitment(GO:0010454) |
0.1 | 0.1 | GO:0042640 | anagen(GO:0042640) |
0.1 | 0.2 | GO:0071731 | response to nitric oxide(GO:0071731) |
0.1 | 0.2 | GO:0014850 | response to muscle activity(GO:0014850) |
0.1 | 0.1 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
0.1 | 0.5 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.1 | 0.5 | GO:0060612 | adipose tissue development(GO:0060612) |
0.1 | 0.1 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.1 | 0.8 | GO:0045104 | intermediate filament cytoskeleton organization(GO:0045104) |
0.1 | 0.1 | GO:0014911 | positive regulation of smooth muscle cell migration(GO:0014911) |
0.1 | 0.1 | GO:0051877 | pigment granule aggregation in cell center(GO:0051877) |
0.1 | 0.2 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.1 | 0.4 | GO:0031000 | response to caffeine(GO:0031000) |
0.1 | 1.5 | GO:0060606 | tube closure(GO:0060606) |
0.1 | 0.1 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
0.0 | 0.1 | GO:0032455 | nerve growth factor processing(GO:0032455) |
0.0 | 0.2 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.0 | 0.3 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.0 | 0.0 | GO:0072162 | mesenchymal cell differentiation involved in kidney development(GO:0072161) metanephric mesenchymal cell differentiation(GO:0072162) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.0 | 0.1 | GO:0051955 | regulation of amino acid transport(GO:0051955) |
0.0 | 0.2 | GO:0043537 | negative regulation of blood vessel endothelial cell migration(GO:0043537) |
0.0 | 0.0 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.0 | 0.2 | GO:0019228 | neuronal action potential(GO:0019228) |
0.0 | 0.2 | GO:0061384 | heart trabecula formation(GO:0060347) heart trabecula morphogenesis(GO:0061384) |
0.0 | 0.2 | GO:0051973 | positive regulation of telomerase activity(GO:0051973) |
0.0 | 0.2 | GO:0055117 | regulation of cardiac muscle contraction(GO:0055117) |
0.0 | 0.4 | GO:0008589 | regulation of smoothened signaling pathway(GO:0008589) |
0.0 | 0.1 | GO:0002753 | cytoplasmic pattern recognition receptor signaling pathway(GO:0002753) nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway(GO:0035872) nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.0 | 0.1 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.0 | 0.2 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.0 | 0.0 | GO:0046639 | negative regulation of alpha-beta T cell differentiation(GO:0046639) |
0.0 | 0.1 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.0 | 0.4 | GO:0048566 | embryonic digestive tract development(GO:0048566) |
0.0 | 0.1 | GO:0071436 | sodium ion export(GO:0071436) |
0.0 | 0.1 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.0 | 0.0 | GO:0010596 | negative regulation of endothelial cell migration(GO:0010596) |
0.0 | 0.0 | GO:0046010 | positive regulation of circadian sleep/wake cycle, non-REM sleep(GO:0046010) |
0.0 | 0.1 | GO:0042501 | serine phosphorylation of STAT protein(GO:0042501) |
0.0 | 0.2 | GO:0019695 | choline metabolic process(GO:0019695) |
0.0 | 0.6 | GO:0090263 | positive regulation of canonical Wnt signaling pathway(GO:0090263) |
0.0 | 0.1 | GO:0010511 | regulation of phosphatidylinositol biosynthetic process(GO:0010511) |
0.0 | 0.0 | GO:0043618 | negative regulation of myeloid leukocyte mediated immunity(GO:0002887) negative regulation of leukocyte degranulation(GO:0043301) regulation of transcription from RNA polymerase II promoter in response to stress(GO:0043618) |
0.0 | 0.4 | GO:0045749 | obsolete negative regulation of S phase of mitotic cell cycle(GO:0045749) |
0.0 | 0.2 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.0 | 0.7 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.0 | 1.0 | GO:0046068 | cGMP metabolic process(GO:0046068) |
0.0 | 0.0 | GO:0060061 | Spemann organizer formation(GO:0060061) |
0.0 | 0.1 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
0.0 | 0.1 | GO:0042339 | keratan sulfate metabolic process(GO:0042339) |
0.0 | 0.1 | GO:0072677 | eosinophil chemotaxis(GO:0048245) eosinophil migration(GO:0072677) |
0.0 | 0.2 | GO:0090399 | replicative senescence(GO:0090399) |
0.0 | 0.1 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
0.0 | 0.8 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.0 | 0.2 | GO:0003214 | cardiac left ventricle morphogenesis(GO:0003214) |
0.0 | 0.2 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.0 | 0.6 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
0.0 | 0.1 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.0 | 0.0 | GO:0061525 | hindgut morphogenesis(GO:0007442) hindgut development(GO:0061525) |
0.0 | 4.1 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.0 | 0.1 | GO:0035725 | sodium ion transmembrane transport(GO:0035725) |
0.0 | 0.2 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.0 | 0.8 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.0 | 0.1 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.0 | 0.3 | GO:0046697 | decidualization(GO:0046697) |
0.0 | 0.1 | GO:0002675 | positive regulation of acute inflammatory response(GO:0002675) |
0.0 | 0.4 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.0 | 0.0 | GO:0072393 | microtubule anchoring at microtubule organizing center(GO:0072393) |
0.0 | 0.1 | GO:0051930 | regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
0.0 | 0.2 | GO:0032740 | positive regulation of interleukin-17 production(GO:0032740) |
0.0 | 0.2 | GO:0050819 | negative regulation of coagulation(GO:0050819) |
0.0 | 0.3 | GO:0042220 | response to cocaine(GO:0042220) |
0.0 | 0.0 | GO:1902667 | regulation of axon guidance(GO:1902667) |
0.0 | 0.2 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.0 | 0.2 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.0 | 0.1 | GO:0051014 | actin filament severing(GO:0051014) |
0.0 | 0.2 | GO:0042745 | circadian sleep/wake cycle(GO:0042745) |
0.0 | 0.0 | GO:0022038 | corpus callosum development(GO:0022038) |
0.0 | 0.1 | GO:0090102 | cochlea development(GO:0090102) |
0.0 | 0.7 | GO:0051925 | obsolete regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051925) |
0.0 | 0.3 | GO:0007320 | insemination(GO:0007320) |
0.0 | 0.3 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.0 | 0.1 | GO:0046113 | nucleobase catabolic process(GO:0046113) |
0.0 | 0.2 | GO:0002544 | chronic inflammatory response(GO:0002544) |
0.0 | 0.0 | GO:0048853 | forebrain morphogenesis(GO:0048853) |
0.0 | 0.2 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.0 | 0.2 | GO:0008228 | opsonization(GO:0008228) |
0.0 | 0.1 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) |
0.0 | 0.1 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.0 | 0.1 | GO:0019471 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) 4-hydroxyproline metabolic process(GO:0019471) peptidyl-proline hydroxylation(GO:0019511) |
0.0 | 0.1 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.0 | 0.0 | GO:0032228 | regulation of synaptic transmission, GABAergic(GO:0032228) |
0.0 | 0.2 | GO:0060259 | regulation of feeding behavior(GO:0060259) |
0.0 | 0.1 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
0.0 | 0.1 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
0.0 | 0.1 | GO:0001885 | endothelial cell development(GO:0001885) |
0.0 | 0.1 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.0 | 0.2 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.0 | 0.1 | GO:0030488 | tRNA methylation(GO:0030488) |
0.0 | 0.1 | GO:0002118 | aggressive behavior(GO:0002118) |
0.0 | 0.1 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
0.0 | 0.0 | GO:0022601 | menstrual cycle phase(GO:0022601) |
0.0 | 0.1 | GO:0051043 | regulation of membrane protein ectodomain proteolysis(GO:0051043) |
0.0 | 0.1 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) |
0.0 | 1.2 | GO:0043062 | extracellular matrix organization(GO:0030198) extracellular structure organization(GO:0043062) |
0.0 | 0.0 | GO:0009111 | vitamin catabolic process(GO:0009111) fat-soluble vitamin catabolic process(GO:0042363) |
0.0 | 0.0 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.0 | 0.0 | GO:0070874 | negative regulation of glycogen metabolic process(GO:0070874) |
0.0 | 0.0 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) positive regulation of signal transduction by p53 class mediator(GO:1901798) |
0.0 | 0.0 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
0.0 | 0.4 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) |
0.0 | 0.1 | GO:0060037 | pharyngeal system development(GO:0060037) |
0.0 | 0.1 | GO:0035058 | nonmotile primary cilium assembly(GO:0035058) |
0.0 | 0.0 | GO:0034380 | high-density lipoprotein particle assembly(GO:0034380) |
0.0 | 0.1 | GO:0003151 | outflow tract morphogenesis(GO:0003151) |
0.0 | 0.7 | GO:0015914 | phospholipid transport(GO:0015914) |
0.0 | 0.1 | GO:0001706 | endoderm formation(GO:0001706) |
0.0 | 0.1 | GO:0042161 | plasma lipoprotein particle oxidation(GO:0034441) regulation of lipoprotein oxidation(GO:0034442) negative regulation of lipoprotein oxidation(GO:0034443) regulation of plasma lipoprotein particle oxidation(GO:0034444) negative regulation of plasma lipoprotein particle oxidation(GO:0034445) lipoprotein modification(GO:0042160) lipoprotein oxidation(GO:0042161) |
0.0 | 0.1 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.0 | 0.1 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.0 | 0.1 | GO:0045905 | translational frameshifting(GO:0006452) positive regulation of translational elongation(GO:0045901) positive regulation of translational termination(GO:0045905) |
0.0 | 0.5 | GO:0014047 | glutamate secretion(GO:0014047) |
0.0 | 0.1 | GO:0007412 | axon target recognition(GO:0007412) |
0.0 | 0.3 | GO:0030901 | midbrain development(GO:0030901) |
0.0 | 0.2 | GO:0009629 | response to gravity(GO:0009629) |
0.0 | 0.0 | GO:0070254 | mucus secretion(GO:0070254) |
0.0 | 0.1 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
0.0 | 0.0 | GO:0032278 | positive regulation of gonadotropin secretion(GO:0032278) positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
0.0 | 0.0 | GO:0034088 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
0.0 | 0.1 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.0 | 0.1 | GO:0015889 | cobalamin transport(GO:0015889) |
0.0 | 0.2 | GO:0071479 | cellular response to ionizing radiation(GO:0071479) |
0.0 | 0.1 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.0 | 0.1 | GO:0015811 | sulfur amino acid transport(GO:0000101) L-cystine transport(GO:0015811) |
0.0 | 0.1 | GO:0045836 | positive regulation of meiotic nuclear division(GO:0045836) positive regulation of meiotic cell cycle(GO:0051446) |
0.0 | 0.2 | GO:0008542 | visual learning(GO:0008542) |
0.0 | 0.2 | GO:0046653 | tetrahydrofolate metabolic process(GO:0046653) |
0.0 | 0.0 | GO:0060023 | soft palate development(GO:0060023) |
0.0 | 0.0 | GO:0003321 | positive regulation of blood pressure by epinephrine-norepinephrine(GO:0003321) |
0.0 | 0.1 | GO:0009822 | alkaloid catabolic process(GO:0009822) |
0.0 | 0.0 | GO:0014834 | skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration(GO:0014834) ossification involved in bone maturation(GO:0043931) |
0.0 | 0.2 | GO:0006241 | GTP biosynthetic process(GO:0006183) UTP biosynthetic process(GO:0006228) CTP biosynthetic process(GO:0006241) pyrimidine ribonucleoside triphosphate metabolic process(GO:0009208) pyrimidine ribonucleoside triphosphate biosynthetic process(GO:0009209) CTP metabolic process(GO:0046036) UTP metabolic process(GO:0046051) |
0.0 | 0.0 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.0 | 0.1 | GO:0032206 | positive regulation of telomere maintenance(GO:0032206) |
0.0 | 0.1 | GO:0010896 | regulation of triglyceride catabolic process(GO:0010896) |
0.0 | 0.2 | GO:0006622 | protein targeting to lysosome(GO:0006622) protein targeting to vacuole(GO:0006623) protein localization to lysosome(GO:0061462) protein localization to vacuole(GO:0072665) establishment of protein localization to vacuole(GO:0072666) |
0.0 | 0.1 | GO:0018101 | protein citrullination(GO:0018101) |
0.0 | 0.1 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.0 | 0.1 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.0 | 0.0 | GO:1901984 | negative regulation of histone acetylation(GO:0035067) negative regulation of protein acetylation(GO:1901984) negative regulation of peptidyl-lysine acetylation(GO:2000757) |
0.0 | 0.1 | GO:0032782 | canalicular bile acid transport(GO:0015722) bile acid secretion(GO:0032782) |
0.0 | 0.4 | GO:0005980 | glycogen catabolic process(GO:0005980) |
0.0 | 0.0 | GO:0039656 | modulation by virus of host gene expression(GO:0039656) |
0.0 | 0.9 | GO:0007219 | Notch signaling pathway(GO:0007219) |
0.0 | 0.0 | GO:0021511 | spinal cord patterning(GO:0021511) |
0.0 | 0.1 | GO:0043113 | receptor clustering(GO:0043113) |
0.0 | 0.0 | GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway(GO:0010803) |
0.0 | 0.1 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
0.0 | 0.0 | GO:0002679 | respiratory burst involved in defense response(GO:0002679) |
0.0 | 0.1 | GO:0051503 | adenine nucleotide transport(GO:0051503) |
0.0 | 0.1 | GO:0032528 | microvillus assembly(GO:0030033) microvillus organization(GO:0032528) |
0.0 | 0.1 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.0 | 0.1 | GO:0046469 | platelet activating factor metabolic process(GO:0046469) |
0.0 | 0.1 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
0.0 | 0.2 | GO:0001756 | somitogenesis(GO:0001756) somite development(GO:0061053) |
0.0 | 0.3 | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) positive regulation of proteasomal protein catabolic process(GO:1901800) |
0.0 | 0.1 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.0 | 0.1 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.0 | 0.1 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.0 | 0.1 | GO:0030539 | male genitalia development(GO:0030539) |
0.0 | 0.1 | GO:0032099 | negative regulation of appetite(GO:0032099) |
0.0 | 0.1 | GO:0042977 | activation of JAK2 kinase activity(GO:0042977) |
0.0 | 0.0 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) positive regulation of membrane depolarization(GO:1904181) |
0.0 | 0.0 | GO:0030146 | obsolete diuresis(GO:0030146) |
0.0 | 0.0 | GO:0002024 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
0.0 | 0.4 | GO:0071804 | cellular potassium ion transport(GO:0071804) potassium ion transmembrane transport(GO:0071805) |
0.0 | 0.1 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.0 | 0.1 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.0 | 0.1 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.0 | 0.0 | GO:2001234 | negative regulation of mitochondrion organization(GO:0010823) negative regulation of release of cytochrome c from mitochondria(GO:0090201) negative regulation of apoptotic signaling pathway(GO:2001234) |
0.0 | 0.0 | GO:0061299 | retina vasculature development in camera-type eye(GO:0061298) retina vasculature morphogenesis in camera-type eye(GO:0061299) obsolete positive regulation of transcription regulator activity(GO:0090047) |
0.0 | 0.0 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.0 | 0.0 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.0 | 0.1 | GO:0010092 | specification of organ identity(GO:0010092) |
0.0 | 0.0 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
0.0 | 0.0 | GO:0044247 | glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
0.0 | 0.1 | GO:0016322 | neuron remodeling(GO:0016322) |
0.0 | 0.0 | GO:0050955 | thermoception(GO:0050955) |
0.0 | 0.0 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.0 | 0.1 | GO:0014037 | Schwann cell differentiation(GO:0014037) |
0.0 | 0.0 | GO:0072070 | loop of Henle development(GO:0072070) |
0.0 | 0.0 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.0 | 0.0 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
0.0 | 0.0 | GO:0061364 | apoptotic process involved in luteolysis(GO:0061364) |
0.0 | 0.1 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.0 | 0.0 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.0 | 0.0 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.0 | 0.0 | GO:0072077 | mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003337) mesenchymal to epithelial transition(GO:0060231) renal vesicle morphogenesis(GO:0072077) metanephric nephron morphogenesis(GO:0072273) metanephric renal vesicle morphogenesis(GO:0072283) |
0.0 | 0.0 | GO:0043084 | penile erection(GO:0043084) |
0.0 | 0.0 | GO:0009756 | carbohydrate mediated signaling(GO:0009756) |
0.0 | 0.2 | GO:0007340 | acrosome reaction(GO:0007340) |
0.0 | 0.0 | GO:0001937 | negative regulation of endothelial cell proliferation(GO:0001937) |
0.0 | 0.0 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
0.0 | 0.1 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.0 | 0.0 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.0 | 0.2 | GO:0042255 | ribosome assembly(GO:0042255) |
0.0 | 0.2 | GO:0051923 | sulfation(GO:0051923) |
0.0 | 0.0 | GO:0051124 | synaptic growth at neuromuscular junction(GO:0051124) |
0.0 | 0.1 | GO:0006895 | Golgi to endosome transport(GO:0006895) Golgi to vacuole transport(GO:0006896) |
0.0 | 0.0 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.0 | 0.0 | GO:2000008 | regulation of protein localization to cell surface(GO:2000008) |
0.0 | 0.0 | GO:0045992 | negative regulation of embryonic development(GO:0045992) |
0.0 | 0.1 | GO:0060736 | prostate gland growth(GO:0060736) |
0.0 | 0.0 | GO:0014721 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
0.0 | 0.0 | GO:0021889 | olfactory bulb interneuron differentiation(GO:0021889) |
0.0 | 0.0 | GO:2000108 | positive regulation of leukocyte apoptotic process(GO:2000108) |
0.0 | 0.0 | GO:0032276 | regulation of gonadotropin secretion(GO:0032276) |
0.0 | 0.0 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.0 | 0.0 | GO:0046852 | positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
0.0 | 0.2 | GO:0007215 | glutamate receptor signaling pathway(GO:0007215) |
0.0 | 0.1 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.0 | 0.1 | GO:0007528 | neuromuscular junction development(GO:0007528) |
0.0 | 0.0 | GO:0042637 | catagen(GO:0042637) |
0.0 | 0.1 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.0 | 0.0 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.0 | 0.0 | GO:0050665 | hydrogen peroxide biosynthetic process(GO:0050665) |
0.0 | 0.0 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.0 | 0.0 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.0 | 0.1 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
0.0 | 0.1 | GO:0098869 | removal of superoxide radicals(GO:0019430) cellular response to oxygen radical(GO:0071450) cellular response to superoxide(GO:0071451) cellular oxidant detoxification(GO:0098869) cellular detoxification(GO:1990748) |
0.0 | 0.0 | GO:0060592 | mammary gland formation(GO:0060592) |
0.0 | 0.0 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.0 | 0.1 | GO:0002070 | epithelial cell maturation(GO:0002070) |
0.0 | 0.0 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular divalent inorganic anion homeostasis(GO:0072501) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.0 | 0.2 | GO:0019233 | sensory perception of pain(GO:0019233) |
0.0 | 0.0 | GO:0009296 | obsolete flagellum assembly(GO:0009296) |
0.0 | 0.0 | GO:0051026 | chiasma assembly(GO:0051026) |
0.0 | 0.0 | GO:0033194 | response to hydroperoxide(GO:0033194) |
0.0 | 0.1 | GO:0046033 | AMP metabolic process(GO:0046033) |
0.0 | 0.0 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.0 | 0.1 | GO:0060395 | SMAD protein signal transduction(GO:0060395) |
0.0 | 0.0 | GO:1902913 | positive regulation of neuroepithelial cell differentiation(GO:1902913) |
0.0 | 0.0 | GO:0046606 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
0.0 | 0.0 | GO:0015732 | prostaglandin transport(GO:0015732) |
0.0 | 0.0 | GO:0019731 | antibacterial humoral response(GO:0019731) |
0.0 | 0.0 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.0 | 0.0 | GO:0045103 | intermediate filament-based process(GO:0045103) |
0.0 | 0.0 | GO:0021904 | dorsal/ventral neural tube patterning(GO:0021904) |
0.0 | 0.0 | GO:0060179 | male courtship behavior(GO:0008049) male mating behavior(GO:0060179) |
0.0 | 0.4 | GO:0045444 | fat cell differentiation(GO:0045444) |
0.0 | 0.0 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.0 | 0.0 | GO:0032288 | myelin assembly(GO:0032288) |
0.0 | 0.0 | GO:0032098 | regulation of appetite(GO:0032098) |
0.0 | 0.0 | GO:0045844 | positive regulation of striated muscle tissue development(GO:0045844) positive regulation of muscle organ development(GO:0048636) positive regulation of muscle tissue development(GO:1901863) |
0.0 | 0.9 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.0 | 0.1 | GO:0042438 | melanin biosynthetic process(GO:0042438) |
0.0 | 0.2 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.0 | 0.1 | GO:0042461 | photoreceptor cell development(GO:0042461) eye photoreceptor cell development(GO:0042462) |
0.0 | 0.0 | GO:0055009 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
0.0 | 0.0 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
0.0 | 0.1 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.0 | 0.1 | GO:0007224 | smoothened signaling pathway(GO:0007224) |
0.0 | 0.0 | GO:0007350 | blastoderm segmentation(GO:0007350) |
0.0 | 0.0 | GO:0009125 | nucleoside monophosphate catabolic process(GO:0009125) |
0.0 | 0.0 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.0 | 0.1 | GO:0060674 | placenta blood vessel development(GO:0060674) |
0.0 | 0.0 | GO:0060840 | artery development(GO:0060840) |
0.0 | 0.0 | GO:0032291 | central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
0.0 | 0.0 | GO:0019240 | citrulline biosynthetic process(GO:0019240) |
0.0 | 0.0 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.0 | 0.0 | GO:0033687 | osteoblast proliferation(GO:0033687) |
0.0 | 0.2 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.0 | 0.0 | GO:0051927 | obsolete negative regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051927) |
0.0 | 0.3 | GO:0007193 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
0.0 | 0.1 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.0 | 0.1 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.0 | 0.0 | GO:0032226 | positive regulation of synaptic transmission, dopaminergic(GO:0032226) |
0.0 | 0.0 | GO:0055015 | ventricular cardiac muscle cell development(GO:0055015) |
0.0 | 0.0 | GO:0016999 | antibiotic metabolic process(GO:0016999) antibiotic biosynthetic process(GO:0017000) |
0.0 | 1.2 | GO:0006813 | potassium ion transport(GO:0006813) |
0.0 | 0.0 | GO:0006590 | thyroid hormone generation(GO:0006590) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 1.5 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.4 | 1.1 | GO:0030934 | anchoring collagen complex(GO:0030934) |
0.4 | 1.1 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.3 | 1.8 | GO:0005587 | collagen type IV trimer(GO:0005587) |
0.2 | 0.2 | GO:0098645 | network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) |
0.2 | 1.0 | GO:0071437 | invadopodium(GO:0071437) |
0.2 | 0.9 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.2 | 1.5 | GO:0005614 | interstitial matrix(GO:0005614) |
0.2 | 0.5 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.1 | 0.7 | GO:0005915 | zonula adherens(GO:0005915) |
0.1 | 0.4 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.1 | 1.0 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.1 | 0.2 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.1 | 0.4 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.1 | 0.2 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.1 | 0.4 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.1 | 0.4 | GO:0030056 | hemidesmosome(GO:0030056) |
0.1 | 0.2 | GO:0070852 | cell body fiber(GO:0070852) |
0.1 | 0.3 | GO:0043256 | laminin complex(GO:0043256) |
0.1 | 0.8 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.1 | 0.7 | GO:0030673 | axolemma(GO:0030673) |
0.1 | 0.6 | GO:0005916 | fascia adherens(GO:0005916) |
0.1 | 0.5 | GO:0031512 | motile primary cilium(GO:0031512) |
0.1 | 1.4 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.1 | 0.2 | GO:0014704 | intercalated disc(GO:0014704) cell-cell contact zone(GO:0044291) |
0.1 | 1.0 | GO:0008328 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.1 | 0.6 | GO:0030122 | AP-2 adaptor complex(GO:0030122) clathrin coat of endocytic vesicle(GO:0030128) |
0.1 | 0.2 | GO:0048179 | activin receptor complex(GO:0048179) |
0.1 | 0.4 | GO:0001527 | microfibril(GO:0001527) |
0.1 | 0.2 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.1 | 0.2 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
0.1 | 0.3 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.1 | 4.0 | GO:0030426 | growth cone(GO:0030426) |
0.1 | 0.1 | GO:0033643 | host(GO:0018995) host cell part(GO:0033643) host intracellular part(GO:0033646) intracellular region of host(GO:0043656) host cell(GO:0043657) other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.1 | 2.7 | GO:0005604 | basement membrane(GO:0005604) |
0.1 | 1.0 | GO:0045178 | basal part of cell(GO:0045178) |
0.1 | 0.4 | GO:0010369 | chromocenter(GO:0010369) |
0.1 | 0.2 | GO:0005954 | calcium- and calmodulin-dependent protein kinase complex(GO:0005954) |
0.1 | 0.3 | GO:0005581 | collagen trimer(GO:0005581) |
0.1 | 0.9 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.1 | 0.9 | GO:0030057 | desmosome(GO:0030057) |
0.1 | 0.5 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.1 | 0.5 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.1 | 0.1 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.0 | 0.3 | GO:0031941 | filamentous actin(GO:0031941) |
0.0 | 0.2 | GO:0032059 | bleb(GO:0032059) |
0.0 | 9.5 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.0 | 0.3 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.0 | 0.2 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.0 | 0.2 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.0 | 0.2 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.0 | 0.1 | GO:0071942 | XPC complex(GO:0071942) |
0.0 | 0.1 | GO:0002142 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) stereocilia ankle link complex(GO:0002142) |
0.0 | 2.6 | GO:0030027 | lamellipodium(GO:0030027) |
0.0 | 0.2 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.0 | 2.6 | GO:0060076 | excitatory synapse(GO:0060076) |
0.0 | 1.1 | GO:0034704 | calcium channel complex(GO:0034704) |
0.0 | 0.1 | GO:0070938 | actomyosin contractile ring(GO:0005826) contractile ring(GO:0070938) |
0.0 | 0.1 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.0 | 0.1 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.0 | 0.7 | GO:0030018 | Z disc(GO:0030018) |
0.0 | 1.4 | GO:0016459 | myosin complex(GO:0016459) |
0.0 | 1.2 | GO:0031012 | extracellular matrix(GO:0031012) |
0.0 | 0.1 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.0 | 0.4 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 1.9 | GO:0034705 | potassium channel complex(GO:0034705) |
0.0 | 0.1 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.0 | 0.1 | GO:0042581 | specific granule(GO:0042581) |
0.0 | 1.0 | GO:0043292 | myofibril(GO:0030016) contractile fiber(GO:0043292) |
0.0 | 0.1 | GO:0042599 | lamellar body(GO:0042599) |
0.0 | 0.1 | GO:0002102 | podosome(GO:0002102) |
0.0 | 2.1 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 0.2 | GO:0016272 | prefoldin complex(GO:0016272) |
0.0 | 0.1 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.0 | 0.1 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.0 | 0.2 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.0 | 0.0 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.0 | 0.5 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.0 | 1.0 | GO:0043296 | apical junction complex(GO:0043296) |
0.0 | 0.1 | GO:0005883 | neurofilament(GO:0005883) |
0.0 | 0.2 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.0 | 0.1 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.0 | 0.0 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) respiratory chain complex IV(GO:0045277) |
0.0 | 0.3 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.0 | 0.1 | GO:0000145 | exocyst(GO:0000145) |
0.0 | 0.0 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.0 | 0.1 | GO:0030686 | 90S preribosome(GO:0030686) |
0.0 | 0.2 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.0 | 0.0 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
0.0 | 0.3 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.0 | 0.0 | GO:0071986 | Ragulator complex(GO:0071986) |
0.0 | 6.0 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 0.1 | GO:0005796 | Golgi lumen(GO:0005796) |
0.0 | 0.0 | GO:0042629 | mast cell granule(GO:0042629) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 2.9 | GO:0001098 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
0.4 | 1.3 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.4 | 1.2 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.4 | 2.0 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.4 | 1.5 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
0.3 | 1.0 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.3 | 0.9 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
0.3 | 0.6 | GO:0050682 | AF-2 domain binding(GO:0050682) |
0.3 | 1.7 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.3 | 1.7 | GO:0005499 | vitamin D binding(GO:0005499) |
0.3 | 0.9 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
0.3 | 1.3 | GO:0042805 | actinin binding(GO:0042805) |
0.3 | 2.3 | GO:0003706 | obsolete ligand-regulated transcription factor activity(GO:0003706) |
0.2 | 0.7 | GO:0003680 | AT DNA binding(GO:0003680) |
0.2 | 0.8 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.2 | 0.8 | GO:0016933 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.2 | 0.6 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.2 | 0.6 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.2 | 0.6 | GO:0045545 | syndecan binding(GO:0045545) |
0.2 | 0.5 | GO:0070215 | obsolete MDM2 binding(GO:0070215) |
0.1 | 0.4 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.1 | 0.6 | GO:0048495 | Roundabout binding(GO:0048495) |
0.1 | 1.0 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.1 | 0.7 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.1 | 0.1 | GO:0000404 | heteroduplex DNA loop binding(GO:0000404) |
0.1 | 1.3 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.1 | 1.7 | GO:0043498 | obsolete cell surface binding(GO:0043498) |
0.1 | 0.7 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.1 | 1.3 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.1 | 0.6 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.1 | 0.4 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.1 | 1.4 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.1 | 0.3 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.1 | 0.8 | GO:0017166 | vinculin binding(GO:0017166) |
0.1 | 0.3 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.1 | 0.3 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.1 | 0.6 | GO:0070696 | transmembrane receptor protein serine/threonine kinase binding(GO:0070696) |
0.1 | 0.4 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.1 | 0.4 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.1 | 1.7 | GO:0005109 | frizzled binding(GO:0005109) |
0.1 | 1.3 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.1 | 0.4 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.1 | 3.3 | GO:0005518 | collagen binding(GO:0005518) |
0.1 | 0.5 | GO:0042153 | obsolete RPTP-like protein binding(GO:0042153) |
0.1 | 0.3 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.1 | 0.3 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.1 | 0.9 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.1 | 0.3 | GO:0032052 | bile acid binding(GO:0032052) |
0.1 | 1.2 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.1 | 0.2 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.1 | 0.4 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
0.1 | 0.2 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.1 | 0.5 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.1 | 0.3 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.1 | 0.3 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.1 | 4.9 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.1 | 1.3 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.1 | 0.3 | GO:0004470 | malic enzyme activity(GO:0004470) |
0.1 | 1.1 | GO:0045296 | cadherin binding(GO:0045296) |
0.1 | 0.4 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.1 | 0.6 | GO:0001968 | fibronectin binding(GO:0001968) |
0.1 | 0.2 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.1 | 0.2 | GO:1901474 | azole transporter activity(GO:0045118) azole transmembrane transporter activity(GO:1901474) |
0.1 | 0.3 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.1 | 0.2 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.1 | 0.3 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.1 | 0.3 | GO:0005534 | galactose binding(GO:0005534) |
0.1 | 0.8 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.1 | 1.0 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 0.2 | GO:0019863 | IgE binding(GO:0019863) |
0.1 | 0.5 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.1 | 1.4 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.1 | 0.2 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.1 | 0.2 | GO:0004082 | bisphosphoglycerate mutase activity(GO:0004082) bisphosphoglycerate 2-phosphatase activity(GO:0004083) phosphoglycerate mutase activity(GO:0004619) |
0.1 | 0.4 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.1 | 0.6 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.1 | 0.2 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.1 | 0.5 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 0.3 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.1 | 0.3 | GO:0044390 | ubiquitin conjugating enzyme binding(GO:0031624) ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.1 | 0.2 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.1 | 0.3 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.1 | 0.2 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.1 | 0.2 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.1 | 0.3 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.1 | 0.1 | GO:0052659 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity(GO:0052659) |
0.0 | 0.4 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.0 | 0.5 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.0 | 0.0 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.0 | 0.1 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
0.0 | 0.2 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.0 | 1.0 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.0 | 0.2 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.0 | 0.4 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.0 | 0.1 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) acyl-CoA desaturase activity(GO:0016215) |
0.0 | 0.6 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.0 | 0.2 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
0.0 | 0.3 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.0 | 0.7 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.0 | 0.1 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
0.0 | 0.2 | GO:0031545 | procollagen-proline 4-dioxygenase activity(GO:0004656) peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.0 | 0.7 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.0 | 0.2 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.0 | 0.2 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.0 | 0.4 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.0 | 0.2 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.0 | 0.1 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.0 | 0.2 | GO:0004064 | arylesterase activity(GO:0004064) |
0.0 | 0.1 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.0 | 0.2 | GO:0004945 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
0.0 | 0.2 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.0 | 0.3 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.0 | 0.1 | GO:0016595 | glutamate binding(GO:0016595) |
0.0 | 0.2 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.0 | 0.2 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
0.0 | 0.8 | GO:0050699 | WW domain binding(GO:0050699) |
0.0 | 0.1 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.0 | 1.1 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.0 | 0.2 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
0.0 | 0.1 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.0 | 0.1 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.0 | 0.1 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.0 | 0.7 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.0 | 0.2 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.0 | 0.4 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.0 | 0.1 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.0 | 0.2 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.0 | 0.1 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.0 | 0.7 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.0 | 0.2 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
0.0 | 0.4 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.0 | 0.1 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.0 | 0.2 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.0 | 0.5 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.0 | 0.3 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.0 | 0.3 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.0 | 0.2 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.0 | 0.4 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.0 | 0.0 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.0 | 0.1 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.0 | 0.1 | GO:0033765 | steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) |
0.0 | 0.4 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.0 | 0.3 | GO:0051378 | serotonin binding(GO:0051378) |
0.0 | 0.1 | GO:0031705 | bombesin receptor binding(GO:0031705) endothelin B receptor binding(GO:0031708) |
0.0 | 0.1 | GO:0043398 | HLH domain binding(GO:0043398) |
0.0 | 0.1 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.0 | 0.3 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.0 | 0.1 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.0 | 0.1 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.0 | 0.2 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.0 | 0.4 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.0 | 0.1 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.0 | 0.1 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.0 | 0.1 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
0.0 | 0.3 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.0 | 0.1 | GO:0030371 | translation repressor activity(GO:0030371) |
0.0 | 0.3 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.0 | 0.4 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.0 | 0.3 | GO:0008430 | selenium binding(GO:0008430) |
0.0 | 0.1 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.0 | 0.1 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.0 | 0.1 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.0 | 0.0 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.0 | 2.3 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.2 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.0 | 0.1 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.0 | 0.3 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.0 | 0.1 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.0 | 0.7 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.0 | 0.3 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.0 | 0.1 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.0 | 0.1 | GO:0019798 | procollagen-proline dioxygenase activity(GO:0019798) |
0.0 | 0.2 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.0 | 0.2 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.0 | 0.2 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.0 | 0.0 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.0 | 0.2 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.0 | 0.1 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.0 | 0.1 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.0 | 0.1 | GO:0015355 | secondary active monocarboxylate transmembrane transporter activity(GO:0015355) |
0.0 | 0.1 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.0 | 0.2 | GO:0000339 | RNA cap binding(GO:0000339) |
0.0 | 0.1 | GO:0051636 | obsolete Gram-negative bacterial cell surface binding(GO:0051636) |
0.0 | 0.1 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.0 | 0.2 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.0 | 0.2 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.0 | 0.1 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.0 | 0.1 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.0 | 0.1 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.0 | 0.1 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.0 | 0.1 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.0 | 0.1 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
0.0 | 0.1 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.0 | 0.1 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.0 | 0.1 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.0 | 0.2 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.0 | 0.0 | GO:0035198 | miRNA binding(GO:0035198) |
0.0 | 0.1 | GO:0031404 | chloride ion binding(GO:0031404) |
0.0 | 0.2 | GO:0001619 | obsolete lysosphingolipid and lysophosphatidic acid receptor activity(GO:0001619) |
0.0 | 0.0 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.0 | 0.1 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.0 | 0.2 | GO:0008175 | tRNA methyltransferase activity(GO:0008175) |
0.0 | 0.0 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.0 | 0.1 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.0 | 0.1 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.0 | 0.1 | GO:0022821 | potassium ion antiporter activity(GO:0022821) |
0.0 | 0.1 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.0 | 0.1 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
0.0 | 0.1 | GO:0043734 | DNA demethylase activity(GO:0035514) DNA-N1-methyladenine dioxygenase activity(GO:0043734) |
0.0 | 0.1 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.0 | 0.1 | GO:0022897 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
0.0 | 1.1 | GO:0008201 | heparin binding(GO:0008201) |
0.0 | 0.3 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.0 | 0.1 | GO:0004803 | transposase activity(GO:0004803) |
0.0 | 0.0 | GO:0016623 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.0 | 0.0 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.0 | 1.7 | GO:0008083 | growth factor activity(GO:0008083) |
0.0 | 0.1 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.0 | 0.1 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.0 | 0.0 | GO:0047894 | flavonol 3-sulfotransferase activity(GO:0047894) |
0.0 | 0.1 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.0 | 0.1 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.0 | 0.1 | GO:0004904 | interferon receptor activity(GO:0004904) |
0.0 | 0.0 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.0 | 0.1 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.0 | 0.0 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.0 | 0.1 | GO:0009975 | cyclase activity(GO:0009975) |
0.0 | 0.0 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.0 | 0.1 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.0 | 0.1 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.0 | 0.0 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.0 | 0.0 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.0 | 0.0 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
0.0 | 0.1 | GO:0019841 | retinol binding(GO:0019841) |
0.0 | 0.1 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.0 | 0.0 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.0 | 0.1 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.0 | 1.9 | GO:0003774 | motor activity(GO:0003774) |
0.0 | 0.0 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.0 | 0.3 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.0 | 0.0 | GO:0016453 | C-acetyltransferase activity(GO:0016453) |
0.0 | 0.1 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.0 | 0.2 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.0 | 0.3 | GO:0030145 | manganese ion binding(GO:0030145) |
0.0 | 0.1 | GO:0010851 | cyclase regulator activity(GO:0010851) guanylate cyclase regulator activity(GO:0030249) |
0.0 | 0.0 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
0.0 | 0.1 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.0 | 0.1 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.0 | 0.1 | GO:0043855 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.0 | 0.3 | GO:0070330 | aromatase activity(GO:0070330) |
0.0 | 0.0 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.0 | 0.1 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.0 | 0.0 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.0 | 0.1 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.0 | 0.1 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.0 | 0.1 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.0 | 3.4 | GO:0030528 | obsolete transcription regulator activity(GO:0030528) |
0.0 | 0.0 | GO:0019956 | chemokine binding(GO:0019956) |
0.0 | 0.6 | GO:0051015 | actin filament binding(GO:0051015) |
0.0 | 6.1 | GO:0005509 | calcium ion binding(GO:0005509) |
0.0 | 0.0 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.0 | 0.0 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.0 | 0.0 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.0 | 0.0 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.0 | 0.0 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.0 | 0.1 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.0 | 0.2 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.0 | 0.0 | GO:0034711 | inhibin binding(GO:0034711) |
0.0 | 0.1 | GO:0016411 | acylglycerol O-acyltransferase activity(GO:0016411) |
0.0 | 0.2 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 0.7 | GO:0022843 | voltage-gated cation channel activity(GO:0022843) |
0.0 | 0.0 | GO:0004516 | nicotinate phosphoribosyltransferase activity(GO:0004516) |
0.0 | 0.1 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.0 | 0.0 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.0 | 0.1 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 0.3 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.2 | 2.5 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.2 | 2.1 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.1 | 1.1 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.1 | 2.0 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 0.6 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.1 | 0.7 | PID CDC42 PATHWAY | CDC42 signaling events |
0.1 | 5.0 | NABA COLLAGENS | Genes encoding collagen proteins |
0.1 | 0.2 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.1 | 0.2 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 0.6 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.1 | 0.3 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.1 | 3.4 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.1 | 1.7 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.1 | 0.6 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 0.4 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.1 | 0.4 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 1.1 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.1 | 0.3 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 0.8 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.1 | 0.1 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.1 | 0.2 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.1 | 1.4 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 1.3 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 2.0 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 0.4 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.0 | 0.1 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 7.3 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.3 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.0 | 0.4 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 1.4 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 0.4 | PID ALK2 PATHWAY | ALK2 signaling events |
0.0 | 1.3 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 0.6 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 1.4 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.0 | 0.1 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.0 | 6.1 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.3 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 4.4 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.0 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.0 | 0.2 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.0 | 0.0 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.0 | 0.4 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.0 | 0.4 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 0.0 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 0.3 | PID P73PATHWAY | p73 transcription factor network |
0.0 | 0.3 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.0 | 0.1 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.0 | 1.0 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.0 | 4.7 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 0.5 | NABA CORE MATRISOME | Ensemble of genes encoding core extracellular matrix including ECM glycoproteins, collagens and proteoglycans |
0.0 | 0.0 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.0 | 0.3 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.0 | 0.1 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.0 | 0.1 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 0.0 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.0 | 0.2 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 3.5 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.2 | 0.2 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.2 | 4.6 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.2 | 3.5 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.1 | 0.7 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 3.7 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.1 | 1.5 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.1 | 0.5 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.1 | 1.4 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.1 | 0.1 | REACTOME SIGNALING BY FGFR IN DISEASE | Genes involved in Signaling by FGFR in disease |
0.1 | 0.9 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.1 | 5.3 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 1.4 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 1.0 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.1 | 0.9 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.1 | 1.8 | REACTOME GRB2 EVENTS IN ERBB2 SIGNALING | Genes involved in GRB2 events in ERBB2 signaling |
0.1 | 0.8 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.1 | 1.6 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.1 | 0.9 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.1 | 0.1 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.1 | 0.4 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.1 | 0.8 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.1 | 0.7 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.1 | 0.2 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.1 | 0.2 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.1 | 0.8 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.1 | 0.6 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.1 | 0.8 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.1 | 0.8 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 1.5 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 0.4 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.0 | 0.2 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.0 | 1.4 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.0 | 0.9 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.0 | 0.4 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.0 | 0.0 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.0 | 0.2 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.0 | 0.8 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.0 | 0.3 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.0 | 0.4 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.0 | 0.3 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.0 | 0.6 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.0 | 0.9 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.0 | 1.8 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.0 | 0.3 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.0 | 0.0 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.0 | 0.8 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 0.4 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.0 | 0.2 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.0 | 0.2 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.0 | 0.4 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.0 | 0.3 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.0 | 0.2 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.0 | 1.6 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 0.3 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.0 | 0.6 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 0.1 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.0 | 0.0 | REACTOME M G1 TRANSITION | Genes involved in M/G1 Transition |
0.0 | 0.3 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.0 | 0.0 | REACTOME SHC RELATED EVENTS | Genes involved in SHC-related events |
0.0 | 0.1 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.0 | 0.2 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.0 | 0.6 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.0 | 0.4 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.0 | 0.3 | REACTOME GABA B RECEPTOR ACTIVATION | Genes involved in GABA B receptor activation |
0.0 | 0.3 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.0 | 0.2 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.0 | 0.3 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.0 | 0.1 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.0 | 0.3 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.0 | 0.4 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.0 | 0.2 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.0 | 0.1 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.0 | 0.2 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
0.0 | 0.4 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
0.0 | 0.2 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.0 | 0.2 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.0 | 0.3 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.0 | 0.1 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.0 | 0.6 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.0 | 0.0 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.0 | 0.0 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
0.0 | 0.2 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.0 | 0.2 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.0 | 0.1 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |